Preclinical Progress of Subunit and Live Attenuated <i>Mycobacterium tuberculosis</i> Vaccines: A Review following the First in Human Efficacy Trial
Tuberculosis (TB) is the global leading cause of death from an infectious agent with approximately 10 million new cases of TB and 1.45 million deaths in 2018. Bacille Calmette-Guérin (BCG) remains the only approved vaccine for <i>Mycobacterium tuberculosis</i> (<i>M. tb</i>,...
| Κύριοι συγγραφείς: | , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
MDPI AG
2020-09-01
|
| Σειρά: | Pharmaceutics |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.mdpi.com/1999-4923/12/9/848 |